Manuel Pedro
Jimenez Garcia
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (9)
2021
-
Empty spiracles homeobox genes EMX1 and EMX2 regulate WNT pathway activation in sarcomagenesis
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
-
Regulation of sarcomagenesis by the empty spiracles homeobox genes EMX1 and EMX2
Cell Death and Disease, Vol. 12, Núm. 6
2020
-
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
Molecular Cancer, Vol. 19, Núm. 1
2019
-
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1
2018
-
NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through sirt1 and PARP
Clinical Cancer Research, Vol. 24, Núm. 5, pp. 1202-1215
2017
-
Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
Oncotarget, Vol. 8, Núm. 35, pp. 58872-58886
-
NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis
Oncotarget, Vol. 8, Núm. 59, pp. 99514-99530
2016
-
The role of PIM1/PIM2 kinases in tumors of the male reproductive system
Scientific Reports, Vol. 6
2015
-
Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
Oncotarget, Vol. 6, Núm. 38, pp. 40557-40574